GABY Inc. entered into an agreement to acquire HempFusion LLC for approximately $0.05 million on April 27, 2023. As consideration, GABY will pay 13 million shares of GABY Through acquisition, GABY will acquire HempFusionTM, Sagely NaturalsTM and apothecannaTM. Closing of the Transaction is subject to certain third party approvals, including the approval of the Canadian Securities Exchange where the GABY Shares are listed for trading. Further, the Transaction requires the approval of at least two-thirds (66%) of the votes cast by the HempFusion shareholders at a special meeting of shareholders to be called by HempFusion, and the satisfaction of customary closing conditions for a transaction of such nature. Subject to satisfaction or waiver of the conditions, the Transaction is expected to close towards the end of Q2 of 2023.

GABY Inc. cancelled the acquisition of HempFusion LLC on June 1, 2023.